News
Stay up to date with the latest news, investments, portfolio updates, and industry recognition.
100+
Active Investors
$30M+
Invested
South Florida
Based, Global Reach.
FEATURED NEWS
NEW WORLD ANGELS BACKS SWIFT SYNC AGAIN AS MIAMI-BORN MED-TECH COMPANY OBTAINS FDA CLEARANCE
New World Angels has invested again in Miami-based Swift Sync following the FDA clearance of its Sync AV II Temporary Pacing Catheter in July 2026.
Fort Lauderdale Founders Get a Roadmap to Angel Funding
The collaboration is designed to strengthen connections among researchers, entrepreneurs, investors, industry leaders, and government stakeholders while accelerating the development and commercialization of technologies emerging from Florida's innovation ecosystem.
New World and University of Central Florida Establish Strategic Collaboration to Advance Space & Defense Innovation
The collaboration is designed to strengthen connections among researchers, entrepreneurs, investors, industry leaders, and government stakeholders while accelerating the development and commercialization of technologies emerging from Florida's innovation ecosystem.
New World Angels Named Angel Investor Group & Syndicate of the Year at MedTech World North America Awards 2026
We are honored to be recognized for our commitment to advancing healthcare innovation and supporting transformative MedTech companies.
Miami Angels Joins With New World Angels To Form Florida’s Premier Early Stage Investor Platform
Miami Angels and New World Angels have joined forces to create Florida’s premier early-stage investor platform, connecting experienced investors across the state’s major innovation hubs to support the next generation of startups.
New World Angels Space & Defense Ventures Group Announces First Flagship Investment in Seagate Space
New World Angels Space & Defense announces its first flagship investment with Seagate Space, marking a key milestone in the group’s launch.
Looking to build the future?
We partner with visionary founders to build category-defining companies.
You will be redirected to Dealum, our funding application platform